These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11774599)
1. Improving the retroviral vector (RV) systems for immunotherapy of cancer. Grabarczyk P; Gryska K; Wysocki PJ; Izycki D; Mackiewicz A Adv Exp Med Biol; 2001; 495():389-92. PubMed ID: 11774599 [No Abstract] [Full Text] [Related]
2. Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer. Boursnell ME; Entwisle C; Ali SA; Sivasubramaniam SD; Reeder S; McLean CS; Blakeley DM; Miller J; Hill S; Shields JG; Inglis SC; Rees RC Adv Exp Med Biol; 1998; 451():379-84. PubMed ID: 10026900 [No Abstract] [Full Text] [Related]
3. Application of gene transfer in cancer immunotherapy. From experimental data to clinical protocols. Favrot MC; Puisieux I Adv Exp Med Biol; 1998; 451():539-41. PubMed ID: 10026924 [No Abstract] [Full Text] [Related]
4. Cancer immunotherapy comes of age. Rosenberg SA Nat Clin Pract Oncol; 2005 Mar; 2(3):115. PubMed ID: 16264884 [No Abstract] [Full Text] [Related]
5. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320 [TBL] [Abstract][Full Text] [Related]
6. Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin. Merrouche Y; Negrier S; Bain C; Combaret V; Mercatello A; Coronel B; Moskovtchenko JF; Tolstoshev P; Moen R; Philip T J Clin Oncol; 1995 Feb; 13(2):410-8. PubMed ID: 7844602 [TBL] [Abstract][Full Text] [Related]
7. Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells. Grabarczyk P; Wysocki PJ; Gryska K; Mackiewicz A Acta Biochim Pol; 2002; 49(2):333-9. PubMed ID: 12362974 [TBL] [Abstract][Full Text] [Related]
8. Cellular vaccine therapies for cancer. Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681 [No Abstract] [Full Text] [Related]
9. Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction: implications for loss of transgene expression. Lamers CH; Gratama JW; Pouw NM; Langeveld SC; Krimpen BA; Kraan J; Stoter G; Debets R Hum Gene Ther; 2005 Dec; 16(12):1452-62. PubMed ID: 16390276 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy on renal-cell carcinoma: magic bullet or tragic insanity? Mickisch GH World J Urol; 1995; 13(3):178-85. PubMed ID: 7550392 [TBL] [Abstract][Full Text] [Related]
12. Improved gene transfer into renal carcinoma cells using adenovirus vector containing RGD motif. Terao S; Acharya B; Suzuki T; Aoi T; Naoe M; Hamada K; Mizuguchi H; Gotoh A Anticancer Res; 2009 Aug; 29(8):2997-3001. PubMed ID: 19661307 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes. Ogasawara M; Rosenberg SA Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762 [TBL] [Abstract][Full Text] [Related]
14. Cell, gene and vaccine based strategies in kidney cancer. Gitlitz BJ; Figlin RA Cancer Treat Res; 2003; 116():183-98. PubMed ID: 14650833 [No Abstract] [Full Text] [Related]
15. Hepatitis A virus receptor blocks cell differentiation and is overexpressed in clear cell renal cell carcinoma. VilĂ MR; Kaplan GG; Feigelstock D; Nadal M; Morote J; Porta R; Bellmunt J; Meseguer A Kidney Int; 2004 May; 65(5):1761-73. PubMed ID: 15086915 [TBL] [Abstract][Full Text] [Related]
16. Expression of apoptotic regulatory molecules in renal cell carcinoma: elevated expression of Fas ligand. Olive C; Cheung C; Nicol D; Falk MC Immunol Cell Biol; 1999 Feb; 77(1):11-8. PubMed ID: 10101681 [TBL] [Abstract][Full Text] [Related]
17. Cellular immunotherapy for cancer: current concepts and clinical perspectives Monitoring immune responses and clinical trials: part II. Spicer J; Quatan N; Plunkett T; Pandha H Clin Oncol (R Coll Radiol); 2004 Sep; 16(6):395-404. PubMed ID: 15487131 [No Abstract] [Full Text] [Related]
18. Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes. Engels B; Noessner E; Frankenberger B; Blankenstein T; Schendel DJ; Uckert W Hum Gene Ther; 2005 Jul; 16(7):799-810. PubMed ID: 16000062 [TBL] [Abstract][Full Text] [Related]
20. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems. Kobayashi M; Okada T; Murakami T; Ozawa K; Kobayashi E; Morita T Urology; 2007 Dec; 70(6):1230-6. PubMed ID: 18158067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]